Michael Golinkoff
Showing 1–6 of 6 transcripts.
- Milken Institute1h 0m
The Business Case for Addressing Social Determinants of Health
Joanne Kenen, Georges Benjamin, Thomas Moriarty, Ashley Perry, Lauren Shweder Biel, Emily Yu, Joanne Cannon, Lauren Schwader-Beal, Catherine Connolly, Michael Golinkoff
A panel of public health leaders and industry executives from organizations including DC Greens, CVS, and Socially Determined defined social determinants of health as critical external factors like housing and food security that drive clinical outcomes. The discussion highlighted actionable case studies, such as DC Greens' Produce Rx program and CVS's expansion of health hubs, which utilize data analytics to prove return on investment and shift SDOH interventions from philanthropic pilots to core business strategies. Participants emphasized that future success requires multisector coalitions to move beyond simple referrals toward shared accountability models that address systemic root causes while leveraging new value-based care incentives.
- Milken Institute58 min
Poised to Break the Bank: Paying for Chronic Disease
Allison Aubrey, Nancy Brown, Thomas Davis, Anand Parekh, Eric, Michael Golinkoff, John Rother, Megan Golden, Jess Leifer, Stephanie Cousins
Geisinger Health's pilot food pharmacy program demonstrated that high-intensity nutritional support significantly lowers chronic disease costs and improves patient outcomes, prompting federal interest through the 2018 Farm Bill despite scalability challenges. While experts advocate for integrated payment models and preventive policies like sugar taxes to address widespread chronic conditions, systemic barriers including data fragmentation, misaligned pharmaceutical incentives, and insufficient medical education continue to hinder broad adoption. Successful scaling now requires multi-payer collaboration to align financial incentives and address interconnected mental health and pain management needs that frequently undermine lifestyle interventions.
- Milken Institute1h 0m
Opioid Addiction: A Crisis Fueled by Stigma
Sarah Karlin-Smith, Kelly Clark, Gary Mendell, Andrey Ostrovsky, Nora Volkow, Ronnie Solomon, Michael Golinkoff
A panel of leading experts, including Dr. Kelly Clark and Gary Mendel, identifies deep-seated stigma as a primary driver of the opioid crisis that obstructs effective funding and policy implementation. To combat this, organizations like Shatterproof propose a seven-point strategy shifting addiction from a criminal justice issue to a chronic disease model, while researchers in Rhode Island demonstrate that medication access for released inmates drastically reduces overdose mortality. Despite these clinical victories, persistent structural barriers such as the X-waiver requirement, inadequate federal budget allocations, and restrictive privacy laws continue to hinder widespread adoption of evidence-based treatments.
- Milken Institute58 min
Poised to Break the Bank: Paying for Chronic Disease
Allison, Anand, Tom, Nancy, Paul Davis, Eric, Michael Golinkoff, John Rother, Megan Golden, Jess Leifer, Stephanie Cousins
A multi-sector consensus addresses the $2.4 trillion annual burden of chronic U.S. diseases by implementing interventions like Geisinger's Food Pharmacy, which reduces healthcare costs by aligning patient acuity with intensive lifestyle support. While capitated payment models and digital innovations such as Omada Health improve scalability and outcomes, structural barriers including payer misalignment and low screening rates for prediabetes necessitate policy shifts toward sugar taxes and multi-payer funding. Concurrently, the medical landscape is pivoting from opioid reliance to holistic pain management and gene therapies, with academic institutions like Kaiser Permanente adapting curricula to prioritize prevention and address the mental health needs of 74% of employees.
- Milken Institute1h 0m
The Business Case for Addressing Social Determinants of Health
Joanne Kenen, Georges Benjamin, Thomas Moriarty, Ashley Perry, Lauren Shweder Biel, Emily Yu, Joanne Cannon, Lauren Schwader-Beal, Katherine Connelly, Michael Golinkoff
Moderated by Joanne Cannon, a panel of public health leaders and corporate strategists redefined the conversation around Social Determinants of Health by prioritizing the business case for intervention over traditional philanthropy. Speakers detailed scalable models such as DC Greens' produce prescription program and CVS's integrated health hubs, which leverage data-driven insights to prove cost savings through medication compliance and reduced emergency room visits. The group concluded that sustainable growth depends on transitioning funding from grants to payer reimbursement within value-based care systems, leveraging political and corporate influence to address root causes like housing instability.
- Milken Institute1h 1m
Opioid Addiction: A Crisis Fueled by Stigma
Robert Redfield, Sarah Carlin-Smith, Dr. Kelly Clark, Gary Mendel, Dr. Andrei Ostrovsky, Jerome Adams, Ronnie Solomon, Michael Golinkoff
A collaborative panel led by Surgeon General officials and researchers from Shatterproof and McKinsey identifies stigma as the primary barrier in the opioid crisis, highlighting how it drives public misunderstanding, provider bias, and critical gaps in Medicaid and federal funding. The group outlines a strategic shift toward humanizing recovery narratives, integrating addiction care into chronic disease management frameworks, and utilizing settlement funds for evidence-based programs to reduce overdose mortality by 50%. By advocating for the removal of restrictive privacy laws like 42 CFR Part 2 and the elimination of the X-waiver, the initiative seeks to dismantle systemic prejudices that currently prevent 60% of treatment facilities from offering FDA-approved medications.